Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HS-10374 tablets in adults with moderate-to-severe plaque psoriasis
CTR20232241Phase 2Completed
- Sponsor
- Changzhou Hengbang Pharmaceutical
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HS-10374 in plaque psoriasis, psoriasis, sponsored by Changzhou Hengbang Pharmaceutical. Started Sep 2023; status: completed.
02
Drugs
HS-10374
03
Conditions
plaque psoriasispsoriasis
Beyond the preview
Go deeper on CTR20232241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232241.